Pfizer says variant identified in South Africa could significantly reduce protective antibodies from vaccine

A laboratory study suggests that the variant of the coronavirus first identified in South Africa may reduce protective antibodies elicited by the Pfizer-BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.

from CBC | Health News https://ift.tt/3awmO5Q